{
    "2020-01-22": [
        [
            {
                "time": "",
                "original_text": "埃克替尼销售继续放量 贝达药业2019净利润预增35%",
                "features": {
                    "keywords": [
                        "埃克替尼",
                        "销售放量",
                        "贝达药业",
                        "净利润预增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "109股昨日获机构买入评级",
                "features": {
                    "keywords": [
                        "机构买入评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}